查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1198220

视网膜手术器械市场 - 增长、趋势、COVID-19 影响和预测 (2023-2028)

Retinal Surgery Devices Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 111 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

在预测期内，视网膜手术设备市场的复合年增长率预计为 7.9%。

COVID-19 对视网膜手术设备市场产生了一些影响，因为视网膜手术通常是需要立即手术的紧急情况。 COVID-19 指南促使世界各地的医生优先考虑基本程序，包括视网膜手术。 然而，延误诊断在大流行期间在一定程度上阻碍了患者的健康。 医生定期进行大流行后手术，大流行后市场将健康增长。

视网膜手术设备通过激光手术、冷冻疗法或巩膜带扣手术修復撕裂或脱落的视网膜。 视网膜疾病种类繁多，其中许多会引起视觉症状。 这些疾病会影响视网膜的任何部分，即眼睛内后壁上的薄组织。

根据世界卫生组织 (WHO) 2021 年的数据，据称到 2050 年，全球 60 岁及以上人口的数量将从 2015 年的 9 亿增加到约 20 亿。 目前，80岁以上的人口约有1.25亿。 老年人群中视网膜疾病、眼睛损伤和糖尿病性视网膜病变患病率的增加是视网膜手术设备市场的主要驱动力。 此外，根据世界卫生组织 2021 年 10 月的一份报告，全球约有 22 亿人患有近视或远视，其中约 10 亿人本可以预防。 视力障碍病例的全球负担很高，表明有治疗的潜力。 因此，对眼科药物的需求非常高，预计这将对本研究预测期内研究的市场增长产生积极影响。

视力丧失专家组 (VEEG) 报告称，到 2021 年，全球将有 11 亿人视力丧失，其中 90% 将生活在中低收入国家 (LMIC)。 此外，根据 2021 年发布的 PubMed 数据，到 2050 年，中东地区的盲人人数将从目前的 4300 万增加到 6100 万（增长 42%）。 同样，中度至重度失明的人数将从目前的 2.95 亿增加到 4.74 亿（增加 61%）。 到2050年，轻度视力障碍人数将从2.58亿增加到3.6亿，近视力障碍人数将从目前的5.1亿增加到8.66亿（增长70%）。。 该数据表明，眼科疾病呈上升趋势，推动了预测期内的市场增长。

然而，与视网膜手术相关的并发症和高昂费用是阻碍市场增长的因素之一。

视网膜手术设备市场趋势

糖尿病视网膜病变领域有望在未来几年实现健康增长

糖尿病性视网膜病变是糖尿病患者视网膜血管受损引起的一种疾病。 糖尿病视网膜病变可能发生在 1 型或 2 型糖尿病患者以及有不受控制的高血糖病史的患者身上。 有两种类型的糖尿病性视网膜病变。 糖尿病视网膜病变有两种类型：非增殖性糖尿病视网膜病变（NPDR），其中眼睛在糖尿病视网膜病变的早期不能形成新血管，以及增殖性糖尿病视网膜病变（PDR），其中新血管开始生长在视网膜中。并且 PDR 在视网膜中形成新血管之前发展。

根据国际糖尿病联合会 (IDF) 的数据，大约 4.63 亿 20-79 岁的成年人患有糖尿病。 到 2045 年，预计将增加到 7 亿人，79% 的糖尿病成年人将生活在低收入和中等收入国家。 随着全球糖尿病负担的增加，糖尿病视网膜病变手术的需求预计将增加，预计将在预测期内推动市场增长。

此外，根据《印度眼科杂誌》2021 年的数据，2021 年糖尿病视网膜病变的患病率男性约为 17%，女性约为 11.8%。 此外，2021 年 11 月发布的 PubMed 数据表明，2021 年糖尿病视网膜病变的全球患病率约为 22.27%，到 2045 年将增加。 因此，随着全球糖尿病视网膜病变患病率的上升，预计该细分市场在预测期内将出现显着增长。

北美将占据很大的市场份额，预计在预测期内也会如此

北美预计将在全球视网膜手术设备市场占据重要市场份额，因为该地区老年人口视网膜疾病患病率上升，糖尿病性视网膜病变患病率高。.

例如，根据疾病预防控制中心的数据，到 2021 年，美国约有 1200 万 40 岁以上的人会出现视力障碍。 细分为 100 万失明者、300 万矫正后视力受损者和 800 万未矫正屈光不正视力受损者。 此外，在美国，大约 6.8% 的 18 岁以下儿童被诊断出患有眼睛或视力障碍。 此外，将近 3% 的 18 岁以下儿童被定义为“盲人”或“视力受损”，这使得即使戴着眼镜或隐形眼镜也难以看清东西。 因此，全美国日益增加的视力障碍负担正在推动对视网膜手术的需求。

此外，《美国医学会杂誌》的数据表明，整个北美地区的糖尿病患病率逐年上升。 它还导致糖尿病视网膜病变增加，占大多数。 例如，国际糖尿病联合会表示，到 2021 年，大约 10.5% 的美国人口将患有糖尿病，并且这一数字将在未来几年呈指数增长。 因此，糖尿病的负担在全国范围内不断增加，所研究的市场预计在预测期内将出现显着增长。

此外，加拿大正在转向新的眼科手术医院，以满足日益增长的眼科手术需求。 例如，2022 年 10 月，位于加拿大温莎的温莎外科中心开设了一个占地 12,000 平方英尺的新设施，为每年需要进行眼科手术的数千人提供服务。 因此，随着眼科中心数量的增加，预计未来几年加拿大的市场将出现强劲增长。

视网膜手术器械市场竞争对手分析

视网膜手术市场是一个竞争激烈的市场，由几家主要参与者组成。 就市场份额而言，它目前由几家主要参与者主导。 一些大公司正在积极收购其他公司以巩固其在全球市场的地位。 一些市场参与者包括 Alcon Inc、IRIDEX Corporation、Bausch & Lomb Incorporated、Carl Zeiss Meditec AG、Topcon Corporation、NIDEK、Ellex Medical Lasers、Lumenis、Leica Microsystems GMBH。

其他好处

  • Excel 格式的市场预测 (ME) 表
  • 三个月的分析师支持

内容

第一章介绍

  • 研究假设和市场定义
  • 调查范围

第二章研究方法论

第 3 章执行摘要

第四章市场动态

  • 市场概览
  • 市场驱动力
    • 老年人口不断增加，眼病患病率不断上升
    • 对微创手术的需求不断增加
  • 市场製约因素
    • 视网膜手术设备成本高
    • 与视网膜手术相关的并发症
  • 波特的五力分析
    • 供应商的议价能力
    • 买方/消费者议价能力
    • 新进入者的威胁
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分（市场规模：百万美元）

  • 按产品类型
    • 玻璃体手术设备和包
    • 视网膜激光设备
    • 手术器械
    • 其他产品
  • 通过申请
    • 糖尿病视网膜病变
    • 视网膜脱离
    • 其他用途
  • 按地区
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东
      • 海湾合作委员会
      • 南非
      • 其他中东地区
    • 南美洲地区
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章竞争格局

  • 公司简介
    • Alcon, Inc
    • IRIDEX Corporation
    • Bausch & Lomb Incorporated
    • Carl Zeiss Meditec AG
    • Topcon Corporation
    • NIDEK CO., LTD
    • Ellex Medical Lasers
    • Lumenis
    • Leica Microsystems GmbH

第7章 市场机会今后动向

简介目录
Product Code: 67635

The retinal surgery devices Market is expected to register a CAGR of 7.9% during the forecast period.

COVID-19 had a slight impact on the retinal surgery devices market as retinal surgery is usually an emergency where an instant operation is needed. With the COVID-19 guidelines, doctors have taken essential procedures on priority across the globe, which also included retinal surgeries. However, a delay in diagnosing the disease has hampered the patient's well-being to some extent during the pandemic. Doctors are performing post-pandemic surgeries regularly, and the market will witness healthy growth over the post-pandemic era.

Retinal surgical devices repair torn or detached retinas through laser surgery, cryotherapy, scleral buckle surgery, etc. Retinal diseases vary widely, but most of them cause visual symptoms. They can affect any part of the retina, a thin layer of tissue on the inside back wall of your eye.

According to the World Health Organization (WHO) 2021 data, by the year 2050, the world's population aged 60 years and older will reach approximately 2 billion, up from 900 million in 2015. Currently, about 125 million people are aged 80 years or older. Growing retinal disorders in the geriatric population, eye injuries, and the rising prevalence of diabetic retinopathy are the key driving factors in the retinal surgery devices market. Further, according to the October 2021 WHO report, about 2.2 billion people worldwide have near or distant vision impairment, of which approximately 1 billion cases could have been prevented. It shows the high burden of cases of vision impairment worldwide and the possibility of treatment. That is why there is a very high demand for ophthalmic drugs, which will positively impact the growth of the market studied during the forecast period of the study.

The Vision Loss Expert Group (VEEG), in 2021, reported that globally 1.1 billion people live with vision loss and 90% of such people live in low and middle-income countries (LMICs). Additionally, PubMed data published in 2021 indicates that the number of blind people will increase from the current 43 million to 61 million (42% increase) by the year 2050 in the Middle East region. Similarly, those with moderate to severe visual impairment will increase from the current 295 million to 474 million (61% increase). People with mild visual impairment will rise from 258 million to 360 million, and those with near vision difficulties will increase from the recent 510 million to 866 million (70% increase) by 2050. The data shows that ophthalmic diseases are rising, propelling the market's growth over the forecasted period.

However, complications associated with retinal surgery and the high cost are some of the factors that can hinder market growth.

Retinal Surgery Devices Market Trends

Diabetic Retinopathy Segment is Expected to Witness Healthy Growth in the Coming Years

Diabetic retinopathy is a condition resulting from damage to the retinal blood vessels in people with diabetes. Diabetic retinopathy can develop in people with type 1 or type 2 diabetes and with a history of uncontrolled high blood sugar levels. Diabetic retinopathy is of two kinds: Nonproliferative diabetic retinopathy (NPDR), in which the eye cannot make new blood vessels during early diabetic retinopathy, and proliferative diabetic retinopathy (PDR), in which new blood vessels begin to grow within the retina.

As per International Diabetes Federation (IDF), approximately 463 million adults aged 20-79 will be living with diabetes. By 2045, it is expected to rise to 700 million adults with diabetes, and 79% of adults who have diabetes will be from low- and middle-income countries. With the increasing burden of diabetes globally, there will be a growing demand for diabetic retinopathy surgeries, which will boost the market growth in the forecast period.

Additionally, according to the Indian Journal of Ophthalmology data in 2021, the diabetic retinopathy prevalence in 2021 was around 17% in males and 11.8% in females. Furthermore, the PubMed data published in November 2021 suggests that the global prevalence of diabetic retinopathy was nearly 22.27% as of 2021, which will increase by 2045. Hence, with the rising worldwide prevalence of diabetic retinopathy, the segment is expected to witness substantial growth over the forecast period.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is expected to hold a significant market share in the global retinal surgery devices market due to the rising prevalence of retinal disorders in the geriatric population and the high prevalence of diabetic retinopathy in this region.

For instance, in 2021, according to the CDC, approximately 12 million people 40 years and over in the US had vision impairment. The number includes 1 million who were blind, 3 million who had vision impairment after correction, and 8 million who had vision impairment due to uncorrected refractive error. Additionally, approximately 6.8% of children younger than 18 years in the US had a diagnosed eye and vision condition. Nearly 3% of children younger than 18 years were blind or visually impaired, defined as having trouble seeing even when wearing glasses or contact lenses. Hence, with the rising burden of vision problems across the country, there is a growing demand for retinal surgeries.

Furthermore, data from the Journal of the American Medical Association suggests that the prevalence of diabetes across the North American region is increasing annually. It is also causing an increase in the majority of diabetic retinopathy. For instance, the International Diabetes Federation has stated around 10.5% of the US population was suffering from diabetes during 2021, and this will grow exponentially in the coming years. Hence, with an increasing burden of diabetes across the country, the market studied is expected to witness substantial growth over the forecasted period.

Additionally, in Canada, there has been an increasing focus on new eye surgery hospitals to fulfill the rising demand for ophthalmic surgeries. For instance, in October 2022, Windsor Surgical Centre, located in Windsor, Canada, opened a new 12,000 Sq.ft facility to serve thousands of people requiring eye surgery annually. Hence, with the rising number of ophthalmic centers, the market studied is expected to witness strong growth in Canada during the coming years.

Retinal Surgery Devices Market Competitor Analysis

The retinal surgery devices Market is consolidated and competitive and consists of several major players. In terms of market share, a few major players are currently dominating it. Some prominent players are vigorously making acquisitions with other companies to consolidate their global market positions. Some market players are Alcon Inc, IRIDEX Corporation, Bausch & Lomb Incorporated, Carl Zeiss Meditec AG, Topcon Corporation, NIDEK CO., LTD, Ellex Medical Lasers, Lumenis, Leica Microsystems GMBH.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Geriatric Population and Increasing Prevalence of Eye Diseases
    • 4.2.2 Increasing Demand for Minimally Invasive Surgeries
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Retinal Surgery Devices
    • 4.3.2 Complications Associated with the Retinal Surgeries
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Bargaining Power of Suppliers
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size - Value in USD million)

  • 5.1 By Product Type
    • 5.1.1 Vitrectomy Machines and Packs
    • 5.1.2 Retinal Laser Equipment
    • 5.1.3 Surgical Instruments
    • 5.1.4 Other Products
  • 5.2 By Application
    • 5.2.1 Diabetic Retinopathy
    • 5.2.2 Retinal Detachment
    • 5.2.3 Other Applications
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Alcon, Inc
    • 6.1.2 IRIDEX Corporation
    • 6.1.3 Bausch & Lomb Incorporated
    • 6.1.4 Carl Zeiss Meditec AG
    • 6.1.5 Topcon Corporation
    • 6.1.6 NIDEK CO., LTD
    • 6.1.7 Ellex Medical Lasers
    • 6.1.8 Lumenis
    • 6.1.9 Leica Microsystems GmbH

7 MARKET OPPORTUNITIES AND FUTURE TRENDS